Cardiac radionuclide imaging in clinical decision making

Hellenic Journal of Nuclear Medicine

Volumn 8, Issue 2, 2005, Pages 95-102

  Moralidis, Efstratios ^a   Anagnostopoulos, Constantinos ^b  

^a Aristotle University of Thessaloniki   (Greece)

^b ROYAL BROMPTON HOSPITAL   (United Kingdom)

Author keywords

Cardiac radionuclide imaging; Clinical decision making; Coronary artery disease; Myocardial perfusion scintigraphy

Indexed keywords

15 (4 IODOPHENYL) 3 METHYLPENTADECANOIC ACID I 123; TECHNETIUM 99M;

ANGINA PECTORIS; CLINICAL PROTOCOL; CORONARY ARTERY DISEASE; CORONARY ARTERY RECANALIZATION; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC ACCURACY; EMERGENCY WARD; EUROPE; EVIDENCE BASED MEDICINE; EXERCISE ELECTROCARDIOGRAPHY; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE ISCHEMIA; HEART MUSCLE PERFUSION; HEART SCINTISCANNING; HOSPITAL DISCHARGE; HUMAN; INTERMETHOD COMPARISON; MEDICAL ASSESSMENT; MEDICAL DECISION MAKING; NUCLEAR MEDICINE; PATIENT SELECTION; PRACTICE GUIDELINE; PROGNOSIS; REVIEW; RISK MANAGEMENT; SENSITIVITY AND SPECIFICITY; SURVIVAL; TIME; UNITED STATES;

CLINICAL TRIALS; CORONARY ARTERIOSCLEROSIS; DECISION MAKING; DECISION SUPPORT SYSTEMS, CLINICAL; HUMANS; PHYSICIAN'S PRACTICE PATTERNS; POSITRON-EMISSION TOMOGRAPHY; PRACTICE GUIDELINES; PREOPERATIVE CARE; PROGNOSIS; RISK ASSESSMENT; RISK FACTORS; VENTRICULAR DYSFUNCTION, LEFT;

EID: 24144476993     PISSN: 00258024     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (86)

1. Beller GA, Zaret BL. Contributions of nuclear cardiology to diagnosis and prognosis of patients with coronary artery disease. Circulation 2000; 101: 1465-1478.
2. Berman DS, Hayes SW, Shaw LJ, Germano G. Recent advances in myocardial perfusion imaging. Curr Probl Cardiol 2001; 26: 1-140.
3. Gibbons R, Chatterjee K, Daley J, et al. ACC/AHA/ACP-ASIM guidelines for the management of patients with chronic stable angina. J Am Coll Cardiol 1999; 33: 2092-2197.
4. Alderman EL, Bourassa MG, Cohen LS, et al. Ten-year follow-up of survival and myocardial infarction in the randomized Coronary Artery Surgery Study. Circulation 1990; 82: 1629-1646.
5. Detre KM, Akaro P, Hultgren H, et al. Long-term mortality and morbidity results of the Veterans Administration randomized trial of coronary artery bypass surgery. Circulation 1985; 72(suppl V): V-84-V-89.
6. Stone GW, Grines CL, Rothbaum D, et al. Analysis of the relative costs and effectiveness of primary angioplasty versus tissue-type plasminogen activator: the primary angioplasty in myocardial infarction (PAMI) trial. J Am Coll Cardiol 1997; 341: 70-76.
7. Pitt B, Waters D, Brown WV, et al. Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease. N Engl J Med 1999; 341: 70-76.
8. Zaret BL, Wackers FJ. Nuclear Cardiology (First of two parts). N Engl J Med 1993; 329: 775-783
9. Loong CY, Anagnostopoulos C. The diagnosis of coronary artery disease by radionuclide myocardial perfusion imaging Heart 2004; 90: V2-9.
10. Wilson RF. Assessing the severity of coronary artery stenoses. N Engl J Med 1996; 334: 1735-1737.
11. Uren NG, Melin JA, Be Bruyne B, et al. Relation between myocardial blood flow and the severity of coronary artery stenosis. N Engl J Med 1994; 330: 1782-1788.
12. Gould KL. Assessing coronary stenosis severity - a recurrent clinical need. J Am Coll Cardiol 1986; 8: 91-94.
13. Gianrossi R, Detrano R, Mulvihill D, et al. Exercise induced ST depression in the diagnosis of coronary disease: a meta-analysis. Circulation 1989; 80: 87-98.
14. Brown KA. Prognosis in stable coronary artery disease. In: Zaret BL, Beller GA eds. Nuclear Cardiology, State of the Art and Future Directions, 2nd edn. St Louis: Mosby; 1999: 331-345.
15. Ladenheim ML, Pollock BH, Rozanski A, et al. Extent and severity of myocardial hypoperfusion as predictors of prognosis in patients with suspected coronary artery disease. J Am Coll Cardiol 1986; 7: 464-471.
16. Iskandrian AS, Chae SC, Heo J, et al. Independent and incremental prognostic value of exercise single-photon emission computed tomographic (SPECT) thallium imaging in coronary artery disease. J Am Coll Cardiol 1993; 22: 665-670.
17. Diaz L, Brunken RC, Blackstone EH, et al. Independent contribution of myocardial perfusion defects to exercise capacity and heart rate recovery for prediction of all-cause mortality in patients with known or suspected coronary heart disease. J Am Coll Cardiol 2001; 37: 1558-1564.
18. Berman DS, Hachamovitch R, Kiat H, et al. Incremental value of prognostic testing in patients with known or suspected ischemic heart disease: a basis for optimal utilization of exercise technetium-99m sestamibi myocardial perfusion single-photon emission computed tomography. J Am Coll Cardiol 1995; 26: 639-647.
19. Hachamovitch R, Berman DS, Kiat H, et al. Exercise myocardial perfusion SPECT in patients without known coronary artery disease: incremental prognostic value and use in risk stratification. Circulation 1996; 93: 905-914.
20. Gibbons R, Chatterjee K, Daley J, et al. ACC/AHA/ACP-ASIM guidelines for the management of patients with chronic stable angina: executive summary and recommendations. Circulation 1999; 99: 2829-2948.
21. O'Keefe JH Jr, Bateman TM, Ligon RW, et al. Outcome of medical versus invasive treatment strategies for non-high-risk ischemic heart disease. J Nucl Cardiol 1998; 5: 28-33.
22. Hachamovitch R, Berman DS, Shaw LJ, et al. Incremental prognostic value of myocardial perfusion single photon emission computed tomography for the prediction of cardiac death: differential stratification for risk of cardiac death and myocardial infarction. Circulation 1998; 97: 535-543.
23. Hachamovitch R, Hayes SW, Friedman JD, et al. Comparison of the short-term survival benefit associated with revascularization compared with medical therapy in patients with no prior coronary artery disease undergoing stress myocardial perfusion single photon emission computed tomography. Circulation 2003; 107: 2900-2907.
24. Abidov A, Hachamovitch R, Rozanski A, et al. Prognostic implications of atrial fibrillation in patients undergoing myocardial perfusion single-photon emission computed tomography. J Am Coll Cardiol 2004; 44: 1062-1070.
25. Azarbal B, Hayes SW, Lewin HC, et al. The incremental prognostic value of percentage of heart rate reserve achieved over myocardial perfusion single-photon emission computed tomography in the prediction of cardiac death and all-cause mortality. J Am Coll Cardiol 2004; 44: 423-430.
26. Lee TH, Goldman L. Evaluation of the patient with acute chest pain. N Engl J Med 2000; 342: 1187-1195.
27. Kontos MC, Jesse RL, Schmidt KL, et al. Value of acute rest sestamibi perfusion imaging for evaluation of patients admitted to the emergency department with chest pain. J Am Coll Cardiol 1994; 23: 1016-1022.
28. Heller GV, Stowers SA, Hendel RC, et al. Clinical value of acute rest technetium-99m tetrofosmin tomographic myocardial perfusion imaging in patients with acute chest pain and nondiagnostic electrocardiograms. J Am Coll Cardiol 1998; 31: 1011-1017.
29. Udelson JE, Beshansky JR, Ballin DS, et al. Myocardial perfusion imaging for evaluation and triage of patients with suspected acute cardiac ischemia: a randomized controlled trial. JAMA 2002; 288: 2693-2700.
30. Radensky PW, Hilton TC, Fulmer H, et al. Potential cost effectiveness of initial myocardial perfusion imaging for assessment of emergency department patients with chest pain. Am J Cardiol 1997; 79: 595-599.
31. Kawai Y, Tsukamoto E, Nozaki Y, et al. Significance of reduced uptake of iodinated fatty acid analogue for the evaluation of patients with acute chest pain. J Am Coll Cardiol 2001; 38: 1888-1894.
32. Boden W, O'Rourke R, Crawford M, et al. Outcomes in patients with acute non-Q wave myocardial infarction randomly assigned to an invasive as compared with a conservative management strategy. N Engl J Med 1998; 338: 1785-1792.
33. Fox KAA, Poole-Wilson PA, Henderson RA, et al. Interventional versus conservative treatment for patients with unstable angina or non ST elevation myocardial infarction: The British Heart Foundation RITA 3 Randomized Trial. Lancet 2002; 360: 743-751.
34. Brown KA. Prognostic value of thallium-201 myocardial perfusion imaging in patients with unstable angina who respond to medical treatment. J Am Coll Cardiol 1991; 17: 1053-1057.
35. Stratman HG, Younis LT, Wittry MD, et al. Exercise technetium-99m myocardial tomography for the risk stratification of men with medically treated unstable angina pectoris. Am J Cardiol 1995; 76: 236-240.
36. ACC/AHA 2002 Guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction. A report of the American College of Cardiology/American Heart Association task force on practice guidelines. www.acc.org.
37. Ryan TJ, Anderson JL, Antman EM, et al. ACC/AHA guidelines for the management of patients with acute myocardial infarction. A report of the ACC/AHA Task Force on Practice Guidelines (Committee in Management of Acute Myocardial Infarction). J Am Coll Cardiol 1996; 28: 1328-1428.
38. Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. The task force on the management of acute coronary syndromes of the European Society of Cardiology. Eur Heart J 2003,23:1809-1840.
39. Tilkemeier PL, Guiney TE, LaRaia PJ, et al. Prognostic value of predischarge low-level exercise thallium testing after thrombolytic treatment of acute myocardial infarction. Am J Cardiol 1990; 66: 1203-1207.
40. Brown KA. Noninvasive risk stratification: Right question, wrong study. J Nucl Cardiol 1994; 1: 112-113.
41. Shaw LJ, Peterson ED, Kesler K, et al. A meta-analysis of predischarge risk stratification after acute myocardial infarction with stress electrocardiographic, myocardial perfusion, and ventricular function imaging. Am J Cardiol 1996; 78: 1327-1337.
42. ACC/AHA 2004 Guidelines for the management of patients with ST-elevation myocardial infarction. A report of the American College of Cardiology/American Heart Association task force on practice guidelines. www.acc.org.
43. Management of acute myocardial infarction in patients presenting with ST-segment elevation. The task force on the management of acute myocardial infarction of the European Society of Cardiology. Eur Heart J 2003; 24: 28-66.
44. Mahmarian JJ, Mahmarian AC, Marks GF, et al. Role of adenosine thallium-201 tomography for defining long-term risk in patients after acute myocardial infarction. J Am Coll Cardiol 1995; 25: 1333-1340.
45. Heller GV, Brown KA, Landin RJ, et al. Safety of early intravenous dipyridamole technetium 99m sestamibi SPECT myocardial perfusion imaging after uncomplicated first myocardial infarction. Early Post MI IV Dipyridamole Study (EPIDS). Am Heart J 1997; 134: 105-111.
46. Brown KA, Heller GV, Landin RS, et al. Early dipyridamole Tc-99m SPECT imaging after acute myocardial infarction predicts in-hospital and post-discharge cardiac events: Comparison with submaximal exercise imaging. Circulation 1999; 100: 2060-2066.
47. Peterson ED, Shaw LJ, Califf RM. Risk stratification after myocardial infarction. ACP Position Paper. Clinical Guideline Part I. Ann Intern Med 1997; 126: 561-582.
48. Brown KA, Rowen M. Prognostic value of a normal exercise myocardial perfusion imaging study in patients with angiographically significant coronary artery disease. Am J Cardiol 1993; 71: 865-867.
49. Pfisterer M, Rickenbacher P, Kiowski W, et al. Silent ischemia after percutaneous transluminal coronary angioplasty: incidence and prognostic significance. J Am Coll Cardiol 1993; 22: 1446-1454.
50. Hecht HS, Shaw LJ, Chin HL, et al. Silent ischemia after coronary angioplasty: evaluation of restenosis and extent of ischemia in asymptomatic patients by tomographic thallium-201 exercise imaging and comparison with symptomatic patients. J Am Coll Cardiol 1991; 17: 670-677.
51. Kosa I, Blasini R, Schneider-Eicke J, et al. Myocardial perfusion scintigraphy to evaluate patients after coronary stent implantation. J Nucl Med 1998; 391307-1311.
52. 201Tl single-photon emission computed tomographic myocardial perfusion imaging after coronary stenting. Am Heart J 2001; 141: 999-1006.
53. ACC/AHA/ASNC Guidelines for the clinical use of cardiac radionuclide imaging - Executive summary. A report of the American College of Cardiology/American Heart Association task force on practice guidelines. Circulation 2003; 108: 1404-1418.
54. FitzGibbon GM, Leach AJ, Kafka HP, et al. Coronary bypass graft fate: long-term angiographic study. J Am Coll Cardiol 1991; 17: 1075-1080.
55. Lauer MS, Lytle B, Pashkow F, et al. Prediction of death and myocardial infarction by screening with exercise thallium testing after coronary-artery-bypass grafting. Lancet 1998; 351: 615-622.
56. Palmas W, Bingham S, Diamond GA, et al. Incremental prognostic value of exercise thallium-201 myocardial single-photon emission computed tomography late after coronary artery bypass surgery. J Am Coll Cardiol 1995; 25: 403-409.
57. Zellweger MJ, Lewin HC, Lai S, et al. When to stress patients after coronary artery bypass surgery? Risk stratification in patients early and late post-CABG using stress myocardial perfusion SPECT: Implications of appropriate clinical strategies. J Am Coll Cardiol 2001; 37: 144-152.
58. Shaw LJ, Eagle KA, Gersh BJ, et al. Meta-analysis of intravenous dipyridamole-thallium-201 imaging (1985 to 1994) and dobutamine echocardiography (1991 to 1994) for risk stratification before vascular surgery. J Am Coll Cardiol 1996; 27: 787-798.
59. ACC/AHA 2002 Guidelines for perioperative cardiovascular evaluation for noncardiac surgery. A report of the American College of Cardiology/American Heart Association task force on practice guidelines. www.acc.org.
60. Palda VA, Detsky AS. Clinical guideline, Part II. Perioperative assessment and management of risk form coronary artery disease. Ann Intern Med 1997; 127: 313-328.
61. Abraham WT, Bristow MR. Specialized centers for heart failure management. Circulation 1997; 96: 2755-2757.
62. Rahimtoola SH. Importance of diagnosing hibernating myocardium: How and in whom? J Am Coll Cardiol 1997; 30: 1701-1706.
63. Mickleborough LL, Maruyama H, Takagi Y, et al. Results of revascularization in patients with severe left ventricular dysfunction. Circulation 1995; 92(9suppl): II73-II79.
64. Gioia G, Milan E, Giubbini R, et al. Prognostic value of tomographic rest-redistribution thallium-201 imaging in medically treated patients with coronary artery disease and left ventricular dysfunction. J Nucl Cardiol 1996; 3: 150-156.
65. Pagley PR, Beller GA, Watson DD, et al. Improved outcome after coronary bypass surgery in patients with ischemic cardiomyopathy and residual myocardial viability. Circulation 1997; 96: 793-800.
66. Braunwald E, Kloner RA. The stunned myocardium: prolonged, postischemic ventricular dysfunction. Circulation 1982; 66: 1146-1149.
67. Johnson LL, Verdesca SA, Aude WY, et al. Postischemic stunning can affect left ventricular ejection fraction and regional wall motion on post-stress gated sestamibi tomograms. J Am Coll Cardiol 1997; 30: 1641-1648.
68. Rahimtoola SH. A perspective on the three large multicenter randomized trials of coronary bypass surgery for chronic stable angina. Circulation 1985; 72(suppl V): 123-135.
69. Vanoverschelde JLJ, Wijns W, Depre C, et al. Mechanisms of chronic regional postischemic dysfunction in humans: new insights from the study of noninfarcted collateral-dependent myocardium. Circulation 1993; 87: 1513-1523.
70. Elsasser A, Schlepper M, Klovekorn WP, et al. Hibernating myocardium: an incomplete adaptation to ischemia. Circulation 1997; 96: 2920-22931.
71. Bax JJ, Vanoverschelde J-LJ, van der Wall EE. Assessment of myocardial viability with thallium-201. In: Iskandrian AS, van der Wall EE eds. Myocardial Viability. 2nd Completely revised edn. Dordrecht: Kluwer Academic Publishers; 2000: 73-89.
72. Haas F, Augustin N, Holper K, et al. Time course of improvement of dysfunctioning myocardium in patients with coronary artery disease and severely depressed left ventricular function after revascularization: correlation with positron emission tomographic findings. J Am Coll Cardiol 2000; 36: 1927-1934.
73. Bax JJ, Poldermans D, van der Wall EE. Evaluation of hibernating myocardium. Heart 2004; 90: 1239-1240.
74. Bax JJ, Schinkel AF, Boersma E, et al. Extensive left ventricular remodeling does not allow viable myocardium to improve in left ventricular ejection fraction after revascularization and is associated with worse long-term prognosis. Circulation 2004; 110 (suppl 1): 1118-1122.
75. Samady H, Elefteriades JA, Abbott BG, et al. Failure to improve left ventricular function after coronary revascularization for ischemic cardiomyopathy is not associated with worst outcome. Circulation 1999; 100: 1298-1304.
76. Di Carli MF, Asgarzadie F, Schelbert HR, et al. Quantitive relation between myocardial viability and improvement in heart failure symptoms after revascularization in patients with ischemic cardiomyopathy. Circulation 1995; 92: 3436-3444.
77. Gunning MG, Chua TP, Harrington D et al. Hibernating myocardium: Clinical and functional response to revascularization. Eur J Cardiothorac Surg 1997; 11: 1105-1112.
78. Elhendy A, Cornel JH, von Domburg RT, et al. Effect of coronary artery bypass surgery on myocardial perfusion and ejection fraction response to inotropic stimulation in patients without improvement in resting ejection fraction. Am J Cardiol 2000; 86: 490-494.
79. Kofoed KF, Bangsgaard R, Carstensen S, et al. Prolonged ischemic heart disease and coronary artery bypass - relation to contractile reserve. Eur J Cardiothor Surg 2002; 21: 417-423.
80. Dalle Mule J, Bax JJ, Zingone B, et al. The beneficial effect of revascularization on jeopardized myocardium: reverse remodeling and improved long-term prognosis. Eur J Cardiothorac Surg 2002; 22: 426.
81. Iskander S, Iskandrian AE. Prognostic utility of myocardial viability assessment. Am J Cardiol 1999; 83: 696-702.
82. Allman KC, Shaw LJ, Hachamovitch R, Udelson JE. Myocardial viability testing and impact on revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis. J Am Coll Cardiol 2002; 39: 1151-1158.
83. Cleland JG, Pennell DJ, Ray SG, et al. Carvedilol hibernating reversible ischaemia trial: marker of success investigators. Lancet 2003; 362: 14-21.
84. Constanzo MR, Augustine S, Bourg R, et al. Selection and treatment of candidates for heart transplantation: a statement for health professionals from the committee on heart failure and cardiac transplantation of the council on clinical cardiology, American Heart Association. Circulation 1995; 92: 3593-3612.
85. Underwood SR, Godman B, Salyani S, et al. Economics of myocardial perfusion imaging in Europe - The EMPIRE study. Eur Heart J 1999; 20: 157-166.
86. Shaw LJ, Hachamovitch R, Berman DS, et al. The economic consequences of available diagnostic and prognostic strategies for the evaluation of stable angina patients: an observational assessment of the value of precatheterization ischemia. J Am Coll Cardiol 1999; 33: 661-669.